Melanoma
Navigation Links
Melanoma at Biology News
Researchers test new therapy for advanced melanoma
Melanoma is a particularly deadly form of skin cancer very resistant to treatment. Researchers at H. Lee Moffitt Cancer Center & Research Institute and the University of South Florida are testing a promising new therapy that prompts the immune system to aid in the fight against melanoma tumors. "This is a milestone clinical trial because it is the first time that electroporation is bei...NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma
A team of researchers, led by Steven A. Rosenberg, M.D., at the National Cancer Institute, part of the National Institutes of Health, have found that patients with advanced melanoma who had not responded to previous therapies experienced a significant reduction in the size of their cancers as a result of receiving a new immunotherapy. This immunotherapy consisted of a combination of chemotherapy...Engineered skin offers clues to melanoma development
When it comes to the deadly skin cancer melanoma, studying functional tissue rather than cell lines may better provide insight into the disease's development, according to new research from a Howard Hughes Medical Institute predoctoral fellow at Stanford University School of Medicine. Though multiple genetic alterations are associated with melanoma development, scientists have not been abl...Newfound roadblock to interferon effectiveness against malignant melanoma
Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells. The finding represents a step forward in understanding the molecular events that govern the growth of this type of cancer and the changes in gene expression and cellular signaling that underlie resistance to established therapies. Malignant melanoma is the deadliest form of sk...Protein amplification in melanoma is possible drug target
A newly discovered gene mutation may account for many cases of immune deficiency, in particular two syndromes known as immunoglobulin A (IgA) deficiency and Common Variable Immunodeficiency (CVID), report researchers in the July issue of Nature Genetics. The discovery may lead to a new diagnostic test for these conditions, which make people highly susceptible to infections and often go unrecogniz...Melanoma at Biology Products
Description:-20 C, Avoid Freeze/Thaw Cycles...
Company:ABR-Affinity BioReagentsDescription:Melanoma Antigen, Family C, 1 (MAGEC1) Rabbit anti-Human Polyclonal Antibody Long term: -20C; Short term: +4C...
Company:Lifespan Biosciences
Company:ABR-Affinity BioReagentsDescription:Melanoma Antigen, Family C, 1 (MAGEC1) Rabbit anti-Human Polyclonal Antibody Long term: -20C; Short term: +4C...
Company:Lifespan Biosciences
Melanoma at Biology Technology
No data found
Search Melanoma biology technology at Google
Search Melanoma biology technology at Yahoo
Search Melanoma biology technology at Msn
Melanoma at Medicine News
Children who suffer sunburn very early in life are far more likely to suffer the most dangerous form of skin cancer, suggest researchers. In humans, melanocytes, the pigment-producing skin cells where melanoma develops, are on the surface of the skin. It is thought that some melanomas are the result of genetic damage caused when the UV radiation strikes these pigment cells. Babies and young child...
Reduction in melanoma death rate
In the last 25 years, in New York, there has been a declining trend in mortality from malignant melanoma, although its frequency has increased. Researchers at the University of Texas, have analysed data on malignant melanoma, the deadliest form of skin cancer, between 1981 and 1999.// They find there has been a 200 per cent increase in cases among men - from 2.0 cases per 150,000 population to 12...Latest device for identifying Melanomas
A research from Australian company has finalized development of a digital screening device it says will take the guesswork out of diagnosing melanomas, the third most common cancer in Australia. Victor Skladnev, managing director of Polartechnics said that in terms of its ability to diagnose melanomas, it matches top specialists.// Image analysis and computer-aided diagnostic software...Specialist surgeon not imperative in melanoma
According to a new study it is observed that the background of the surgeon does not affect the outcome in melanoma. Researchers at the University of Glasgow have surveyed 4,139 melanoma patients who had their tumour removed between 1979 and 1999.// They found the outcomes to be similar, whether the operating surgeon had a background in dermatology, cosmetic work, or general surgery. This is in co...Tumour marker for melanoma found
According to a recent study it is observed that a molecular marker is linked to prognosis in malignant melanoma. In cancer research today, there is increasing emphasis on looking for molecules// specific to that cancer which might aid in monitoring the progression of the disease. Scientists at New York University now report on a molecular marker called HDM2 which appears to be important in tracki...Melanoma at Medicine Products
No data found
Search Melanoma medicine products at Google
Search Melanoma medicine products at Yahoo
Search Melanoma medicine products at Msn
Melanoma at Medicine Technology
IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
- Results show UVIDEM was well-tolerated with signs of durabledisease control in advanced melanoma patients - IRVINE, Calif., June 05, 2007 /PRNewswire-FirstCall/ -- IDMPharma, Inc. today presented preliminary results from a Phase IIUVIDEM (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). Theresults showed that UVIDEM was well tolerated with evidence ofefficacy and induction of immune...Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
LEXINGTON, Mass.--(BUSINESS WIRE)--Jun 5, 2007 - SyntaPharmaceuticals Corp., (NASDAQ: SNTA) a biopharmaceutical companyfocused on discovering, developing, and commercializing smallmolecule drugs to treat severe medical conditions, today announcedencouraging results from the analysis of overall survival (OS) timefor patients in the Company's double-blind, randomized, controlled,multi-center...Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
Clinical Phase I and II data presented at American Society ofClinical Oncology (ASCO) 2007 Annual Meeting CHICAGO, June 05, 2007 /PRNewswire-FirstCall/ -- Medarex, Inc.and Bristol-Myers Squibb Company today presented results frommultiple clinical studies of ipilimumab (MDX-010), aninvestigational immunotherapy, for patients with advanced melanoma.The results demonstrated an anti-tumor res...CHICAGO – June 2, 2007 – Long-term treatment withpegylated interferon alfa-2b in stage III melanoma had asignificant and sustained impact on relapse-free survival (RFS),according to the results of the largest adjuvant trial everconducted in patients with stage III melanoma. Results of the PhaseIII study, led by...
HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- KosanBiosciences Incorporated presented preliminary data from a Phase 2monotherapy trial showing that tanespimycin demonstrated antitumoractivity and tolerability in patients with metastatic melanoma,including one patient with a BRAF mutation (V600E) who had failedprior chemotherapy (within 6 weeks of initiation) and while ontanesp...
Melanoma at Medicine Dictionary
Other TagsHabitatRootsDoubleDoubleDoubleDoubleIntegrationChromosomeChromosomeChromosomeChromosomeTurningTurningBiomarkersBiomarkersGraspingOther Contentscortisolcortisolcortisolcortisolcoughingcoughingcrabscrabscrabscradlecradlecradlecradlecramp
GrizzliesHabitatRootsDoubleIntegrationChromosomeTurningGenpathwayShuttingDecodingAnammoxCooperationBiomarkersGrasping
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2[0] Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting[0] People With GERD More Likely to Develop Asthma[0] Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors [0] Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi
(Date:7/25/2008)...cephalus, or "water on the brain" must have shunts...to reduce harmful pressure. , While shunts do t...dren is very high for a variety of reasons, which ... to replace the shunt, bringing with it more hospi...cations and an increased risk of death. , Now a...
(Date:7/25/2008)...ntially contain a naturally occurring toxin called...lth according to a review paper published in the l...e of Food and Agriculture (JSFA). , However, th...ted area is enough to eliminate most of the GAs to...t the levels of GA in potatoes can be controlled e...
(Date:7/24/2008)...s they do human athletes, but the playbook of mole...and development in plant cells is far more complic...y plant biologists at the Carnegie Institution use... to identify key links in the steroid signaling ch...te genes could lead not only to enhanced harvests ...
(Date:7/24/2008)...alovirus (CMV), which most commonly affects people...hospital intensive-care patients who have no immun...chers have found. CMV infection is also associated...) stays independent of other causes, according to ...al of the American Medical Association . , Abou...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3CMV infections affect more than just patients with compromised immune systems, researchers find 2Oncolytics Biotech Inc Announces Details of 2008 Annual Shareholder Meeting 5087 1Oncolytics Biotech Inc Announces Details of 2008 Annual Shareholder Meeting 5087 2Biocept Launches Noninvasive Prenatal Rh 28D 29 Diagnostic at Annual ACOG Scientific Meeting 5085 1Biocept Launches Noninvasive Prenatal Rh 28D 29 Diagnostic at Annual ACOG Scientific Meeting 5085 2Anesiva Announces Publication of Phase 3 Zingo 28TM 29 Data in the Journal Pediatrics 1964 1Anesiva Announces Publication of Phase 3 Zingo 28TM 29 Data in the Journal Pediatrics 1964 2Anesiva Announces Publication of Phase 3 Zingo 28TM 29 Data in the Journal Pediatrics 1964 3Anesiva Announces Publication of Phase 3 Zingo 28TM 29 Data in the Journal Pediatrics 1964 4Anesiva Announces Publication of Phase 3 Zingo 28TM 29 Data in the Journal Pediatrics 1964 524 Hour Fitness Gets Personal in Groundbreaking New Brand Campaign 18366 124 Hour Fitness Gets Personal in Groundbreaking New Brand Campaign 18366 224 Hour Fitness Gets Personal in Groundbreaking New Brand Campaign 18366 3[0] Antimicrobial sutures reduce infections in brain shunt surgery, study finds[0] 'Green' potato health risk can be eliminated by cutting away affected area[0] Plant steroids offer new paradigm for how hormones work[1] CMV infections affect more than just patients with compromised immune systems, researchers find
| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |